Adolescents and young adults who are current smokers are recommended to receive MenACWY and MenB vaccines

Adolescents and young adults (aged 15–24 years) who are current smokers are recommended to receive:

• 1 dose of MenACWY vaccine
• 2 doses of MenB vaccine

There is no preference for either brand of MenACWY vaccine – MenQuadfi, Menveo, or Nimenrix – for adolescents and young adults.

There is no preference for either brand of MenB vaccine — Bexsero or Trumenba — for adolescents and young adults.

Bexsero and Trumenba are not interchangeable. The same vaccine should be used for both vaccine doses.

Smoking tobacco increases the risk of carrying meningococcal bacteria in the upper respiratory tract. It also increases the risk of transmitting the bacteria to close contacts. Smokers are at greater risk of meningococcal disease because they have higher meningococcal carriage rates than non-smokers.^8-10